Literature DB >> 27928371

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star.

Frederico Castelo Moura1, Douglas Kazutoshi Sato2, Carolina Medeiros Rimkus3, Samira Luisa Apóstolos-Pereira4, Luana Michelli de Oliveira4, Claudia Costa Leite3, Kazuo Fujihara5, Mario Luiz Ribeiro Monteiro1, Dagoberto Callegaro4.   

Abstract

A 44-year-old man presented with severe right visual loss. The right fundus examination showed marked optic disc oedema associated with partial macular star. Serological blood tests for infectious agents were all negative. Serum aquaporin-4 antibody was negative but anti-MOG (myelin oligodendrocyte glycoprotein) was positive. Magnetic resonance revealed extensive lesion in right optic nerve. There was no visual improvement after intravenous therapy. Patient had no further attacks after follow-up. Optic disc oedema with macular star is found in several infectious and non-inflammatory disorders, but it has not been reported in optic neuritis (ON) associated with autoantibodies to myelin oligodendrocyte glycoprotein (anti-MOG).

Entities:  

Keywords:  Devic’s syndrome; macular star; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody; optic neuritis

Year:  2015        PMID： 27928371      PMCID： PMC5122939          DOI： 10.3109/01658107.2015.1084332

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN： 0165-8107


  9 in total

1.  MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.

Authors:  Tetsuya Akaishi; Douglas Kazutoshi Sato; Ichiro Nakashima; Takayuki Takeshita; Toshiyuki Takahashi; Hiroshi Doi; Kazuhiro Kurosawa; Kimihiko Kaneko; Hiroshi Kuroda; Shuhei Nishiyama; Tatsuro Misu; Toru Nakazawa; Kazuo Fujihara; Masashi Aoki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-03-06       Impact factor: 10.154

2.  Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.

Authors:  Kensuke Ikeda; Naoki Kiyota; Hiroshi Kuroda; Douglas Kazutoshi Sato; Shuhei Nishiyama; Toshiyuki Takahashi; Tatsuro Misu; Ichiro Nakashima; Kazuo Fujihara; Masashi Aoki
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

3.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Dagoberto Callegaro; Marco Aurelio Lana-Peixoto; Patrick J Waters; Frederico M de Haidar Jorge; Toshiyuki Takahashi; Ichiro Nakashima; Samira Luisa Apostolos-Pereira; Natalia Talim; Renata Faria Simm; Angelina Maria Martins Lino; Tatsuro Misu; Maria Isabel Leite; Masashi Aoki; Kazuo Fujihara
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

4.  Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Ichiro Nakashima; Toshiyuki Takahashi; Tatsuro Misu; Patrick Waters; Hiroshi Kuroda; Shuhei Nishiyama; Chihiro Suzuki; Yoshiki Takai; Kazuo Fujihara; Yasuto Itoyama; Masashi Aoki
Journal:  Neurology       Date:  2013-05-15       Impact factor: 9.910

5.  Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

Authors:  Thomas R Hedges; Laurel N Vuong; Alberto O Gonzalez-Garcia; Carlos E Mendoza-Santiesteban; Maria Luz Amaro-Quierza
Journal:  Arch Ophthalmol       Date:  2008-06

Review 6.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

Review 7.  Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.

Authors:  C Kaur; W S Foulds; E A Ling
Journal:  Prog Retin Eye Res       Date:  2008-10-04       Impact factor: 21.198

8.  Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

Authors:  Simone Mader; Viktoria Gredler; Kathrin Schanda; Kevin Rostasy; Irena Dujmovic; Kristian Pfaller; Andreas Lutterotti; Sven Jarius; Franziska Di Pauli; Bettina Kuenz; Rainer Ehling; Harald Hegen; Florian Deisenhammer; Fahmy Aboul-Enein; Maria K Storch; Peter Koson; Jelena Drulovic; Wolfgang Kristoferitsch; Thomas Berger; Markus Reindl
Journal:  J Neuroinflammation       Date:  2011-12-28       Impact factor: 8.322

9.  Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.

Authors:  Russell C Dale; Esther M Tantsis; Vera Merheb; Raani-Yogeeta A Kumaran; Nese Sinmaz; Karrnan Pathmanandavel; Sudarshini Ramanathan; David R Booth; Louise A Wienholt; Kristina Prelog; Damien R Clark; Gilles J Guillemin; Chai K Lim; Emily K Mathey; Fabienne Brilot
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.